COUNTERFEIT DRUGS IN INDIA

Size: px
Start display at page:

Download "COUNTERFEIT DRUGS IN INDIA"

Transcription

1 COUNTERFEIT DRUGS IN INDIA a part presentation from the on-going dissertation Global Threat of Counterfeit Drugs A Study Covering Extent of Problem and Anticounterfeit Measures in Europe & India By, Viraj Mehta Ph.D. supervisor Prof. Dr. H.G. Schweim University of Bonn, April 2008 Viraj Mehta/ April 2008 Counterfeit Drugs in India 1

2 WHO Definition A counterfeit pharmaceuticals product is a product that is deliberately and fraudulently mislabeled with respect to identity and/ or source. Counterfeit products may include products with correct ingredients, wrong ingredients, without active ingredients, with the incorrect quantity of active ingredient or with fake packaging Viraj Mehta/ April 2008 Counterfeit Drugs in India 2

3 Counterfeit drugs A global problem It is a vast, global and underreported problem WHO estimates 10% of total drugs on the world market, worth billion US$, to be counterfeit Fake drugs are responsible for killing numerous lives around the globe e.g. 1,92,000 patients have died in China just during 2001 Interpol categorized it as a form of organized crime and means to finance their activities by some terrorist groups Viraj Mehta/ April 2008 Counterfeit Drugs in India 3

4 Extent of counterfeit drugs in India Source Estimation Estimation based on Media up to 35% Various sources Indian State s drugs administration authorities Associated Chambers of Commerce & Industry of India 0.24 to 0.47% 10.64% (sub-standard) 20% 38% (of Govt. supplies) Samples tested during Various surveys WHO Govt. of India Nigerian National Agency for Food & Drugs Administration Pharmaceutical Research & Manufacturers of America Special 301 Submission % in developing countries, however no official estimation for India due to lack of studies No official estimations due to lack of studies Identified India as one of the sources of fake drugs supply to the country Identified India as significant source of counterfeit drugs through online pharmacies Viraj Mehta/ April 2008 Counterfeit Drugs in India 4

5 Indian drugs regulatory system The Central Drug Standard Control Organization (CDSCO) is a decentralized body with distinct functions of the Central and State agencies and the drugs manufacturing licenses are responsibility of States Definition of spurious drugs introduced in the Drugs & Cosmetics Act during 1982 There exists a gray-zone between spurious (intentional act) and sub-standard drugs (non-intentional act) Viraj Mehta/ April 2008 Counterfeit Drugs in India 5

6 Reasons for counterfeit drugs in India Poverty Inadequate health system Inadequate regulatory infrastructure Lack of enforcement of existing laws Weak penal actions Lack of coordination between various agencies Agglomerated and uncontrolled retail outlets Insecure distribution network Corruption and conflict of interest Internet sale of drugs Viraj Mehta/ April 2008 Counterfeit Drugs in India 6

7 Measures to combat counterfeit drugs in India I The essence of drugs anti-counterfeiting strategy for India lies in: Determining real extent of the problem Strengthening regulatory infrastructure and effective collaboration between various agencies Making judicial proceedings effective by speedy trials and imposing tougher penalties Securing medicinal products totally - from raw material procuring until effective post-marketing vigilance system Dealing with corruption Improving healthcare system Increased international collaboration Viraj Mehta/ April 2008 Counterfeit Drugs in India 7

8 Measures to combat counterfeit drugs in India II Based on the Mashelkar committee report A comprehensive examination of drug regulatory issues, including the problem of spurious drugs, major amendments to central drugs Legislation The Drugs & Cosmetics Act is under consideration Proposed major changes are: - creation of Central Drugs Authority (CDA) as an autonomous body, which will issue manufacturing licenses centrally - strengthening of regulatory infrastructure and testing facilities - provision of stringent penalties for drugs related crime Viraj Mehta/ April 2008 Counterfeit Drugs in India 8

9 Thank You Viraj Mehta/ April 2008 Counterfeit Drugs in India 9

Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law

Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law SSFFC drugs are medical products that: do not contain any specific active substances, irrespective of the indication

More information

The Spreading Plague of Counterfeiting

The Spreading Plague of Counterfeiting The Spreading Plague of Counterfeiting Harvey Bale Director General International Federation of Pharmaceutical Manufacturers Associations (IFPMA) PSF Assembly Stockholm 25 October 2003 Rising Tide of a

More information

What should be done to ensure the safety, efficacy and quality of medicines?

What should be done to ensure the safety, efficacy and quality of medicines? Does quality of medicines matter? Yes, it matters. Medicines including vaccines save lives and prevent diseases and epidemics only if they are safe, efficacious, of good quality and are used rationally.

More information

2007 FIP World Congress of Pharmacy and Pharmaceutical Sciences September 3, 2007 Beijing, China

2007 FIP World Congress of Pharmacy and Pharmaceutical Sciences September 3, 2007 Beijing, China 2007 FIP World Congress of Pharmacy and Pharmaceutical Sciences September 3, 2007 Beijing, China Topic: International Trade Issues Related to Counterfeit Medicines and the Need for Global Cooperation Jeffrey

More information

Counterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.

Counterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd. Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com

More information

Counterfeit Medicines Toolkit 8. Questions and Answers

Counterfeit Medicines Toolkit 8. Questions and Answers Counterfeit Medicines Toolkit 8. Questions and Answers Materials developed in collaboration with: 6/5/2010 Q&A: Definition of Counterfeit Medicine (1) Q: What is the problem with the current definition?

More information

Counterfeit Pharmaceuticals. in Canada. The counterfeit criminal market. in Canada. No country is immune from counterfeit drugs

Counterfeit Pharmaceuticals. in Canada. The counterfeit criminal market. in Canada. No country is immune from counterfeit drugs Criminal Intelligence Service Canada August 2006 Counterfeit Pharmaceuticals in Canada The counterfeit criminal market in Canada Counterfeit goods can be categorized into industry sectors: entertainment

More information

LOGO. Falsification of Medicines. Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry

LOGO. Falsification of Medicines. Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry LOGO Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry Falsification of Medicines Dr. As. Prof. Anastasiya Sladkova Dr. Sci. Prof. Natalya Loginova 1 Questions

More information

Federation of Saint Kitts and Nevis

Federation of Saint Kitts and Nevis Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Federation of Saint Kitts and Nevis 2009 EVALUATION OF PROGRESS IN DRUG CONTROL

More information

Counterfeit Medicines - The (Unknown?) Threat with many Faces

Counterfeit Medicines - The (Unknown?) Threat with many Faces Counterfeit Medicines - The (Unknown?) Threat with many Faces EUROPEAN SECURITY CONFERENCE INITIATIVE & CPSI FINAL SYMPOSIUM 4 th March 2010 Panel: Actual Risk vs. Felt Security Cases and Conclusions Dr.

More information

Background COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES. 8-15% of global pharmaceutical sales is counterfeit

Background COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES. 8-15% of global pharmaceutical sales is counterfeit COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES Michael H. Anisfeld Globepharm Consulting, USA Michael H. Anisfeld Globepharm Consulting 313 Pine Street Deerfield IL 60015, USA Phone:

More information

Danger to public health from counterfeit medicines

Danger to public health from counterfeit medicines WP.6 Seminar Background from WHO English only 13 June 2007 UNECE International Seminar on Product Safety and Counterfeiting (Geneva, 5 p.m.- 6 a.m. November 2007) Danger to public health from counterfeit

More information

Bill C-51 and Natural Health Products - The Facts

Bill C-51 and Natural Health Products - The Facts Bill C-51 and Natural Health Products - The Facts 1. How will Bill C-51 change the way natural health products are regulated? Bill C-51 will not affect the way that natural health products are regulated

More information

Intellectual Property Rights Fiscal Year 2012 Seizure Statistics. Prepared by U.S. Customs and Border Protection Office of International Trade

Intellectual Property Rights Fiscal Year 2012 Seizure Statistics. Prepared by U.S. Customs and Border Protection Office of International Trade Intellectual Property Rights Fiscal Year 2012 Seizure Statistics Prepared by U.S. Customs and Border Protection Office of International Trade Intellectual Property Rights Fiscal Year 2012 Seizure Statistics

More information

Counterfeit Medicinal Products. POLAND Wardyński & Partners

Counterfeit Medicinal Products. POLAND Wardyński & Partners Counterfeit Medicinal Products POLAND Wardyński & Partners CONTACT INFORMATION Ewa Butkiewicz, Ph.D. Wardyński & Partners Al. Ujazdowskie 10 00-478 Warsaw, Poland 48.22.437.82.00 ewa.butkiewicz@wardynski.com.pl

More information

MHRA Anti-counterfeiting Strategy and Supply Chain Guidance

MHRA Anti-counterfeiting Strategy and Supply Chain Guidance Safeguarding public health MHRA Anti-counterfeiting Strategy and Supply Chain Guidance PQG Annual Meeting for QPs 24 Mar 2010 Nimo Ahmed Head of Intelligence Medicines and Healthcare products Regulatory

More information

THE MEDICRIME CONVENTION

THE MEDICRIME CONVENTION Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The MEDICRIME Convention in a few words Crime linked to the manufacture, distribution and sale

More information

14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region

14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region 14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region Budiono Santoso Team Leader Essential Medicines & Technologies, World Health Organization,

More information

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND

More information

Council of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes

Council of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes Counterfeiting of medical products and similar crimes involving threats to public health are a

More information

Tobacco Free Ireland Action Plan

Tobacco Free Ireland Action Plan Tobacco Free Ireland Action Plan Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies

More information

THE MEDICRIME CONVENTION

THE MEDICRIME CONVENTION Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The Medicrime Convention in a few words Crime linked to the manufacture, distribution and sale

More information

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.11.2009 SEC(2009) 1621 final COMMISSION STAFF WORKING DOCUMENT Report on the implementation of the Council Recommendation of 2 December 2002 on the prevention

More information

AFR/RC60/16 21 July 2010 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH. Sixtieth session Malabo, Equatorial Guinea, 30 August 3 September 2010

AFR/RC60/16 21 July 2010 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH. Sixtieth session Malabo, Equatorial Guinea, 30 August 3 September 2010 21 July 2010 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixtieth session Malabo, Equatorial Guinea, 30 August 3 September 2010 Provisional agenda item 9 REPORT OF THE REGIONAL TASKFORCE ON PREVENTION

More information

Congressional Record December 9, 2009 S12786-S12787

Congressional Record December 9, 2009 S12786-S12787 Congressional Record December 9, 2009 S12786-S12787 Mr. MENENDEZ. I thank the distinguished chairman of the Senate Finance Committee for yielding me the time. Madam President, I rise in strong opposition

More information

SUBJECT: Cannabis legislation and implications for the City of Burlington

SUBJECT: Cannabis legislation and implications for the City of Burlington Page 1 of Report CM-11-17 SUBJECT: Cannabis legislation and implications for the City of Burlington TO: FROM: Committee of the Whole City Manager's Office Report Number: CM-11-17 Wards Affected: All File

More information

European Medicines Enforcement Network

European Medicines Enforcement Network Safeguarding public health European Medicines Enforcement Network 14 th ICDRA, Singapore December 2010 Nimo Ahmed Head of Intelligence Medicines and Healthcare products Regulatory Agency Outline MHRA Enforcement

More information

Barry Ewy, PharmD, JD, MHA CEO Blessings International

Barry Ewy, PharmD, JD, MHA CEO Blessings International Barry Ewy, PharmD, JD, MHA CEO Blessings International 1 I have the following financial relationships to disclose: I am an Employee of Blessings International. I will not discuss off label use and/or investigational

More information

2017 CPFI Annual Meeting 1

2017 CPFI Annual Meeting 1 I have the following financial relationships to disclose: I am an Employee of Blessings International. I will not discuss off label use and/or investigational use in my presentation. Barry Ewy, PharmD,

More information

Hong Kong. Macao Passed Food Safety Law

Hong Kong. Macao Passed Food Safety Law THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S. GOVERNMENT POLICY Voluntary - Public Date: 6/17/2013 GAIN Report Number:

More information

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation 2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,

More information

Economic Impact of Counterfeiting

Economic Impact of Counterfeiting Economic Impact of Counterfeiting Why current practice makes it so difficult to assess economic impact and steps toward a solution Alexander A Theil, M.A. Transatlantic IP Collaboration Conference April

More information

MEDICINES REGULATORY AUTHORITIES: CURRENT STATUS AND THE WAY FORWARD. Report of the Regional Director EXECUTIVE SUMMARY

MEDICINES REGULATORY AUTHORITIES: CURRENT STATUS AND THE WAY FORWARD. Report of the Regional Director EXECUTIVE SUMMARY 17 June 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: FRENCH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 8.5 MEDICINES REGULATORY AUTHORITIES: CURRENT STATUS

More information

Overview Consumer Health Products Law and Compliance Issues

Overview Consumer Health Products Law and Compliance Issues Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services Consumer

More information

Report of the Task Force on Drug Diversion through Institutional Outlets

Report of the Task Force on Drug Diversion through Institutional Outlets Report of the Task Force on Drug Diversion through Institutional Outlets Members Present: Wiki Erickson (TX); David Flashover (NY); Donald Gibson (MN); Susan Ksiazek (NY); Wallace Nelson (NC). Not Present:

More information

Fighting Cartels: What We Mean by Deterrence Carlos Mena Labarthe Head of the Investigative Authority

Fighting Cartels: What We Mean by Deterrence Carlos Mena Labarthe Head of the Investigative Authority Fighting Cartels: What We Mean by Deterrence Carlos Mena Labarthe Head of the Investigative Authority November 2016 1. DETERRENCE 2. ELEMENTS OF DETERRENCE 3. EFFECTIVE CARTEL ENFORCEMENT & OUTREACH 4.

More information

Council of Europe The Medicrime Convention

Council of Europe The Medicrime Convention Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes What is a counterfeit medical product? It is a product with a deliberately false representation

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Argentina 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council Update on the Legalization and Regulation of Cannabis January 8, 2018 Regular Meeting of Delta Council Regulatory Authority for Cannabis Federal authority: Cultivation & Manufacturing Licensing, inspection,

More information

Country specific case studies Best practices to combat counterfeit medicines and to protect public health. Luc Besançon FIP Project Coordinator

Country specific case studies Best practices to combat counterfeit medicines and to protect public health. Luc Besançon FIP Project Coordinator Country specific case studies Best practices to combat counterfeit medicines and to protect public health Luc Besançon FIP Project Coordinator Patient safety and pharmaceutical products Internet Counterfeit

More information

on the advertising of medicinal products for human use

on the advertising of medicinal products for human use 30. 4. 92 Official Journal of the European Communities No L 113 / 13 COUNCIL DIRECTIVE 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use THE COUNCIL OF THE EUROPEAN COMMUNITIES,

More information

Globalization, Challenges, and Global Solutions

Globalization, Challenges, and Global Solutions Globalization, Challenges, and Global Solutions Deborah M. Autor, Esq. Director, Office of Compliance Center for Drug Evaluation and Research IOM Meeting on Strengthening Core Elements of Regulatory Systems

More information

SNo Quarter 2 National Survey on Drug Abuse: 21 The extent and patterns of drug abuse in India have been changing The Board appreciates the decision b

SNo Quarter 2 National Survey on Drug Abuse: 21 The extent and patterns of drug abuse in India have been changing The Board appreciates the decision b ANNEX URE TO POLICY PLAN OF ACTI ON SNo 1 National Drug Control System: 11 The Board commends the Government of India for its strong commitment to the objectives of the international drug control treaties

More information

Legalization, Regulation and Restriction of Access to Cannabis

Legalization, Regulation and Restriction of Access to Cannabis Legalization, Regulation and Restriction of Access to Cannabis Presentation to UNSM May 26th, 2017 Departments of Justice, Health and Wellness and Finance and Treasury Board Today Origin and Federal Context

More information

14 th International Conference of Drug Regulatory Authorities 30 th November December 2010 Singapore

14 th International Conference of Drug Regulatory Authorities 30 th November December 2010 Singapore 14 th International Conference of Drug Regulatory Authorities 30 th November 2010 3 December 2010 Singapore CURRENT REGULATORY CHALLENGES RELATING TO HERBAL MEDICINES: ADULTERATION OF HERBAL MEDICINES

More information

GROUP 1. Marching towards a tobacco free world.

GROUP 1. Marching towards a tobacco free world. GROUP 1 Marching towards a tobacco free world. Chair : Dr Douglas Bettcher(WHO/HQ) Facilitator : Dr Nyo Nyo( WHO/SEARO) Rappoteur: Pubudu Sumanasekara ( ADIC/Sri Lanka) Sherub Gyeltshen(Bhutan) What is

More information

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov

More information

AFRICAN ECONOMIC DEVELOPMENT PLAN

AFRICAN ECONOMIC DEVELOPMENT PLAN AFRICAN ECONOMIC DEVELOPMENT PLAN Dr. Brylyne Chitsunge Pan African Ambassador for Food Security Chancellor of Pan-African Agriculture and Commerce University Cannabis Science Scientific Advisory Board

More information

Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes

Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes Policy Group on Tobacco Jan 2015 1 Table of contents Background... 2 Policy

More information

Cannabis Legalization August 22, Ministry of Attorney General Ministry of Finance

Cannabis Legalization August 22, Ministry of Attorney General Ministry of Finance Cannabis Legalization August 22, 2018 Ministry of Attorney General Ministry of Finance Federal Cannabis Legalization and Regulation The federal Cannabis Act received Royal Assent on June 21, 2018 and will

More information

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Report. Uganda Pharmaceutical Sector Scan JUNE 2010 Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.

More information

Traditional Medicine: Overview on national policies and regulations of traditional medicine

Traditional Medicine: Overview on national policies and regulations of traditional medicine Traditional Medicine: Overview on national policies and regulations of traditional medicine Kallesh Danappa Jayappa, Ph.D student Infectious minds presentation 22 nd June 2011 WHO initiatives Major challenges:

More information

The Danish Medicines Agency s availability strategy

The Danish Medicines Agency s availability strategy låst DECEMBER 2016 The Danish Medicines Agency s availability strategy 2017 2021 Danish Medicines Agency, 2016 This publication may be freely quoted with appropriate acknowledgement of the source. Images

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Paraguay 2005 PROGRESS REPORT IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Counterfeits have harmful effects on patients' health and can kill. Counterfeits frustrate efforts to deal with high burdens of disease

Counterfeits have harmful effects on patients' health and can kill. Counterfeits frustrate efforts to deal with high burdens of disease Counterfeits have harmful effects on patients' health and can kill Counterfeits frustrate efforts to deal with high burdens of disease Counterfeits undermine health care systems Increased international

More information

QUESTIONNAIRE. Submission Information. Date of submission: 29 June Information for follow-up purposes. P.O. Box Dar es salaam.

QUESTIONNAIRE. Submission Information. Date of submission: 29 June Information for follow-up purposes. P.O. Box Dar es salaam. Implementation of the recommendations adopted by the Twenty-sixth Meeting of Heads of National Drug Law Enforcement Agencies, Africa, held in Addis Ababa from 19 to 23 September 2016 QUESTIONNAIRE Submission

More information

ORDINANCE NO

ORDINANCE NO ORDINANCE NO. 01-2017 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF SEMINOLE, FLORIDA, REGARDING MEDICAL CANNABIS; IMPOSING A TEMPORARY MORATORIUM ON THE SALE OF MEDICAL CANNABIS AND ON THE ESTABLISHMENT

More information

This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices

This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices agencia española de medicamentos y productos sanitarios This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices ROYAL DECREE

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

From Wikipedia, the free encyclopedia

From Wikipedia, the free encyclopedia 1 of 6 11/24/2010 11:43 PM From Wikipedia, the free encyclopedia The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United

More information

Legal Framework: Counterfeit Medicines.

Legal Framework: Counterfeit Medicines. Legal Framework: Counterfeit Medicines. AIFA and the actions against drugs counterfeiting Marcello Chiavoni Zagreb, November 2014 Public Declaration of transparency/interests* The view and opinions expressed

More information

Progress Report: A Comprehensive Evaluation of the FDA's Battle against Counterfeit Drugs

Progress Report: A Comprehensive Evaluation of the FDA's Battle against Counterfeit Drugs Progress Report: A Comprehensive Evaluation of the FDA's Battle against Counterfeit Drugs The Harvard community has made this article openly available. Please share how this access benefits you. Your story

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Mexico 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Counterfeit Drugs Affect Even Legitimate Sources: Hospitals and Pharmacies

Counterfeit Drugs Affect Even Legitimate Sources: Hospitals and Pharmacies Counterfeit Drugs Affect Even Legitimate Sources: Hospitals and Pharmacies Charlie Cichon, Executive Director National Association of Drug Diversion Investigators Homeland Security 2014 Each year, more

More information

Ensuring the gap between science and practice is filled safely - MHRA

Ensuring the gap between science and practice is filled safely - MHRA Safeguarding public health Ensuring the gap between science and practice is filled safely - MHRA Diane Leakey Head of Information and Communications, MHRA April 2012 Agenda Who is MHRA? Why we have regulation?

More information

The Challenge of Counterfeit Drugs in the Republic of Armenia. Master of Public Health Integrating Experience Project. Problem Solving Framework

The Challenge of Counterfeit Drugs in the Republic of Armenia. Master of Public Health Integrating Experience Project. Problem Solving Framework The Challenge of Counterfeit Drugs in the Republic of Armenia Master of Public Health Integrating Experience Project Problem Solving Framework By Gevorg Mamikonyan, BS, MPH Candidate Advising Team Varduhi

More information

Colorado s Cannabis Experience Doug Friednash

Colorado s Cannabis Experience Doug Friednash Colorado s Cannabis Experience Doug Friednash (dfriednash@bhfs.com) Brownstein Hyatt Farber Schreck, LLP Denver, Colorado 1 Marijuana in the US 62% of Americans say the use of marijuana should be legal.

More information

REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015

REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015 REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015 Noting the efforts made by Member States to achieve the goals set in the 2009 Political Declaration

More information

Forest Stewardship Council

Forest Stewardship Council This document is for survey respondents only, and not for external distribution. FSC misleading claims survey: a summary of findings Background to the Forest Stewardship Council and misleading claims The

More information

DECREE. President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law

DECREE. President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law Number: (116) Date: 18 th November 2008 Article 1: DECREE Of President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law I, hereby, enforce the Law on Medicine which is approved

More information

TOWN OF KENNEBUNK MORATORIUM ORDINANCE ON RETAIL MARIJUANA ESTABLISHMENTS AND RETAIL MARIJUANA SOCIAL CLUBS

TOWN OF KENNEBUNK MORATORIUM ORDINANCE ON RETAIL MARIJUANA ESTABLISHMENTS AND RETAIL MARIJUANA SOCIAL CLUBS TOWN OF KENNEBUNK MORATORIUM ORDINANCE ON RETAIL MARIJUANA ESTABLISHMENTS AND RETAIL MARIJUANA SOCIAL CLUBS WHEREAS, a ballot initiative to legalize, regulate and tax marijuana for nonmedicinal purposes

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Saint Lucia 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Scottish Health Action on Alcohol Problems. Alcohol (Licensing, Public health and Criminal Justice) (Scotland) Bill

Scottish Health Action on Alcohol Problems. Alcohol (Licensing, Public health and Criminal Justice) (Scotland) Bill Scottish Health Action on Alcohol Problems Alcohol (Licensing, Public health and Criminal Justice) (Scotland) Bill This submission comes from Scottish Health Action on Alcohol Problems (SHAAP). SHAAP is

More information

Legalization of Cannabis- Overview

Legalization of Cannabis- Overview Legalization of Cannabis- Overview Presentation to Regional Council Education Workshop February 15, 2018 Joy Hulton, Regional Solicitor 1 Overview Background Federal Cannabis Framework Provincial Legislation

More information

ASEAN Activities on Increasing Access to ARV and HIV Related Supplies

ASEAN Activities on Increasing Access to ARV and HIV Related Supplies ASEAN Activities on Increasing Access to ARV and HIV Related Supplies Consultation on Integrating Prevention and Management of STI/HIV/AIDS into Reproductive, Maternal and Newborn Health Services and the

More information

Regulatory Impact Statement. The International Convention on Standards of Training, Certification and Watchkeeping 1978

Regulatory Impact Statement. The International Convention on Standards of Training, Certification and Watchkeeping 1978 Regulatory Impact Statement Introducing a Blood Alcohol Limit for On-duty Seafarers The International Convention on Standards of Training, Certification and Watchkeeping 1978 Agency disclosure statement

More information

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law

More information

Cannabis Retail Store Licensing in Ontario. General Committee December 10, 2018

Cannabis Retail Store Licensing in Ontario. General Committee December 10, 2018 1 Cannabis Retail Store Licensing in Ontario General Committee December 10, 2018 Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Presentation Outline Federal Regulatory

More information

PUBLIC CONSULTATION DOCUMENT

PUBLIC CONSULTATION DOCUMENT EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT

More information

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security INTER AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security FORTY NINTH REGULAR SESSION May 4 6, 2011 Paramaribo, Suriname OEA/Ser.L/XIV.2.49 CICAD/doc.1860/11 rev.2 corr.

More information

Informal meeting of the Justice and Home Affairs Ministers Sopot July 2011

Informal meeting of the Justice and Home Affairs Ministers Sopot July 2011 Informal meeting of the Justice and Home Affairs Ministers Sopot 18-19 July 2011 New challenges to EU anti-drug policy. I. Introduction Every hour an EU citizen dies of a drug overdose. There are as many

More information

CANNABIS IN YOUR COMMUNITY. A Presentation to CPAA Conference May 2017

CANNABIS IN YOUR COMMUNITY. A Presentation to CPAA Conference May 2017 CANNABIS IN YOUR COMMUNITY A Presentation to CPAA Conference May 2017 WE LL BE THERE FOR YOUR HIGHS AND LOWS! Presented by: MUNICIPAL Charlotte A. St. Dennis Senior Associate Edmonton Office cstdennis@brownleelaw.com

More information

COMBATING THE ILLICIT TRADE OF CIGARETTE AND TOBACCO PRODUCTS ANTI ILLICIT TRADE CONFERENCE CAPE TOWN, SOUTH AFRICA 9 11 NOVEMBER 2015

COMBATING THE ILLICIT TRADE OF CIGARETTE AND TOBACCO PRODUCTS ANTI ILLICIT TRADE CONFERENCE CAPE TOWN, SOUTH AFRICA 9 11 NOVEMBER 2015 COMBATING THE ILLICIT TRADE OF CIGARETTE AND TOBACCO PRODUCTS Colonel John Matroos National Coordinator Head Office Directorate for Priority Crime Investigation South African Police Service matroosjohn@saps.gov.za

More information

Why is Medicine Quality Important?

Why is Medicine Quality Important? Why is Medicine Quality Important? March 3, 2015 Boston University School of Public Health Pharmaceutical Track Spring Symposium Laura Krech, MPH Consultant, based in Boston Promoting the Quality of Medicines

More information

Partnerships for Public Awareness and Patient Protection The GPHF-Minilab Project

Partnerships for Public Awareness and Patient Protection The GPHF-Minilab Project Partnerships for Public Awareness and Patient Protection The GPHF-Minilab Project German Pharma Health Fund (GPHF) Global Pharmaceutical AntiCounterfeiting Forum, Geneva, Switzerland, September 22-25,

More information

SFIREG Issue Paper: Pesticide Use on Cannabis State Established Pesticide Residue Action Levels

SFIREG Issue Paper: Pesticide Use on Cannabis State Established Pesticide Residue Action Levels SFIREG Issue Paper: Pesticide Use on Cannabis State Established Pesticide Residue Action Levels Introduction to Issue: In recent years, with the approval of medical and recreational use of marijuana in

More information

Pharmaceutical Product Recall Procedures in India, South Africa and China

Pharmaceutical Product Recall Procedures in India, South Africa and China Research Article Pharmaceutical Product Procedures in India, South Africa and China M.P. Venkatesh*, Bigoniya D., T.M. Pramod Kumar Regulatory Affairs Group, Department of Pharmaceutics, JSS College of

More information

Explanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis

Explanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis Explanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis Published by The Honourable William Francis Morneau, P.C., M.P. Minister of Finance September 2018

More information

KEY FEATURES OF DRUG POLICY

KEY FEATURES OF DRUG POLICY KEY FEATURES OF DRUG POLICY Selection of essential Drugs. 1) The core of the concept of selection of essential medicines is that use of a limited number of carefully selected medicines based on Standard

More information

Share your thoughts - write a letter to the editor. Tackling addiction. August 22, Word from Winkler

Share your thoughts - write a letter to the editor. Tackling addiction. August 22, Word from Winkler Share your thoughts - write a letter to the editor. Tackling addiction The church s public witness By the Rev. Cynthia Abrams August 22, 2011 Word from Winkler Alabama law imperils ministry Alcohol and

More information

Regulatory & Quality Control Provisions for Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) Drugs

Regulatory & Quality Control Provisions for Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) Drugs Regulatory & Quality Control Provisions for Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) Drugs Dr D.C. Katoch Adviser (Ay.) & Head- Drugs Control Ministry of AYUSH, Govt. of India AYUSH A: Ayurveda

More information

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS SEPTEMBER 23, 2009 COUNCIL OF THE CONVENTION SECTION ON THE QUALITY OF FOOD INGREDIENTS AND DIETARY SUPPLEMENTS INTRODUCTION The 1994 Dietary Supplement

More information

Policy Options for the Regulation of Electronic Cigarettes

Policy Options for the Regulation of Electronic Cigarettes Policy Options for the Regulation of Electronic Cigarettes Consultation submission This submission was completed by: (name) Position (if applicable): Evon Currie General Manager, Community and Public Health

More information

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,

More information

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014) AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred

More information

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last

More information

Model. Medical Access to Marihuana first established on a case by case basis using exemptions

Model. Medical Access to Marihuana first established on a case by case basis using exemptions Table 1: Legal Framework for Cannabis in Canada Legal Framework Section 56 Exemptions under Controlled Drugs and Substances Act (1999) Marihauna Medical Access Regulations (MMAR) 2001 Marihuana for Medical

More information

Definitions of substandard and falsified medical products

Definitions of substandard and falsified medical products EXECUTIVE SUMMARY EXECUTIVE SUMMARY Introduction In 2015, the World Health Organization (WHO) Member State mechanism commissioned a study on the public health and socioeconomic impact of substandard and

More information

IDENTIFICATION OF OPPORTUNITIES FOR SACCHAROMYCES

IDENTIFICATION OF OPPORTUNITIES FOR SACCHAROMYCES IDENTIFICATION OF OPPORTUNITIES FOR SACCHAROMYCES BOULARDII Prepared by: CPL Business Consultants CAB International Centre, Wallingford, Oxfordshire, OX10 8DE Tel: +44 1491 829 346, info@cplconsult.com,

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Jamaica 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information